A Randomized Controlled Trial of a Nurse Delivered Stage-matched Smoking Cessation Intervention to Promote Heart Health of Cardiac Patients

Smoking Cessation Clinical Trial

Official title:

A Randomized Controlled Trial of a Nurse Delivered Stage-matched Smoking Cessation Intervention to Promote Heart Health of Cardiac Patients

Clinical Trial Details — Status: Completed

Administrative data

• NCT number: NCT00563199
• Other study ID #: NTWC/CREC/325/04
• Secondary ID: HARECCTR0500022H
• Status: Completed
• Phase: N/A
• First received: November 21, 2007
• Last updated: June 14, 2011
• Start date: March 2002
• Est. completion date: December 2005

Study information

• Verified date: June 2011
• Source: Hospital Authority, Hong Kong
• Contact: n/a
• Is FDA regulated: No
• Health authority: Hong Kong: Ethics Committee
• Study type: Interventional

Clinical Trial Summary

This study is a randomized controlled trial designed to evaluate the effectiveness of a nurse delivered stage-matched intervention to cardiac patients for cessation of tobacco use. Review of literature shows that there is a clear lack of empirical evidence on (1) using nurses to deliver stage-matched smoking cessation interventions, and (2) the effectiveness of such intervention for cardiac patients in Chinese populations. The ultimate goal of the intervention achieve a higher quit rate in the intervention group than in the controls. In addition, the change in the patient's smoking behaviour such as reduction of the number of cigarettes smoked, and progression to a higher stage of readiness to quit, will also be measured. This study is the first step to address the urgently needed data for (1) promoting the delivery of nurse-run stage-matched smoking cessation interventions to help patients stop smoking, (2) developing smoking cessation policy and programmes in the hospitals and for the health care system, and (3) contributing an evidence-based approach to orientate clinical services towards prevention, so as to reduce premature deaths and the enormous disease burden of our society.

Recruitment information / eligibility

• Status: Completed
• Enrollment: 1824
• Est. completion date: December 2005
• Gender: Both
• Age group: N/A and older

Eligibility

Inclusion Criteria:

• Patient who is admitted to the participating centres and is a current smoker who has smoked daily in the past 7 days prior to hospitalization.

• Patient speaks and reads Cantonese/Chinese

Exclusion Criteria:

• Patient who is clinically too ill and not suitable to complete questionnaire and/or receive intervention.

• Patient who does not speak or read Chinese

Study Design

Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double-Blind

Related Conditions & MeSH terms

• Smoking
• Smoking Cessation

Intervention

Behavioral:
• nurse-delivered stage-matched smoking cessation counseling

Locations

Country	Name	City	State
China	Caritas Medical Centre	Hong Kong
China	Pamela Youde Nethersole Eastern Hospital	Hong Kong
China	Princess Margaret Hospital	Hong Kong
China	Queen Elizabeth Hospital	Hong Kong
China	Queen Mary Hospital	Hong Kong
China	Ruttonjee Hospital / Tang Shiu Kin Hospital	Hong Kong
China	Tseung Kwan O Hospital	Hong Kong
China	Tuen Mun Hospital	Hong Kong
China	Tung Wah Hospital	Hong Kong
China	United Christian Hospital	Hong Kong

Sponsors (2)

Lead Sponsor	Collaborator
Hospital Authority, Hong Kong	The Hong Kong Research Grants Council (RGC)

Country where clinical trial is conducted

China, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Quitting--to achieve higher quit rate in the cardiac patients (coronary artery disease) who are smokers		continuous abstinence for one month at the time of 3, 6 and 12 month follow up
Secondary	Reduction of the number of cigarettes smoked		at the time of 3, 6 and 12 month follow up
Secondary	Progression to a higher stage of readiness to quit		at the time of 3, 6 and 12 month follow up